Search Results
274 items found for "protein expression"
- Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)
August 29, 2024 Abstract "The growth hormone-releasing hormone receptor (GHRHR) belongs to Class B1 of G protein-coupled
- Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors
Long-COVID is currently under heavy scrutiny and existing data on the role of auto-immune reaction to G-protein
- Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy
the tumor microenvironment (TME), purinergic receptors such as ATP-gated ion channels P2X1-5 and G protein-coupled
- Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation
Transforming growth factor-β (TGFβ) is essential for alveologenesis and lung repair, and the G protein Cyclical mechanical stretch-induced TGFβ activation required Gαq/11 signalling and serine protease activity
- Principles of Pharmacology in Drug Discovery II
My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Further investigations in vitro and in vivo revealed that the levels of an anti-apoptotic protein, Bcl
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
Previously, we identified potent positive crosstalk between insulin/IGF-1 receptors and G protein-coupled
- GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway
This autoimmune loop in psoriasis pathogenesis is influenced by G protein-coupled receptor (GPCR) signalling
- Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways
underlying this synergistic pharmacodynamic interaction, liquid chromatography-mass spectrometry-based proteomic capture pancreatic cancer cell responses to gemcitabine and trabectedin, alone and combined, at the proteome Part I described the proteomic workflow and drug effects on the upstream portion of the SPD model related Drug combination effects on protein changes in the cell cycle- and apoptosis pathways contribute to the multi-scale quantification platform for evaluating drug effects across multiple scales, spanning the proteomic
- Ep 60 with Dr. Josephine (Pina) Cardarelli
mission is to discover and develop highly effective cancer therapeutics by targeting heteromers of G protein-coupled
- Sponsorship Prospectus for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Adhesion GPCR Workshop 2024, a premier scientific meeting bringing together leaders and innovators in G Protein-Coupled Complimentary exhibition booth in a prominent location at the event venue. Recognition in press releases and media coverage. Complimentary registration for 3 representatives. Gold Sponsor Prominent recognition as a Gold sponsor in all promotional materials.
- Ep 144 with Dr Aurélien Rizk
They also discussed the challenges of system dependency in data and the need to express data in a uniform They also shared their preference for small molecule therapies over protein therapeutics. They expressed their anticipation for future interactions.
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
My expertise includes biochemical approaches, proteomics and transcriptomics to name a few. My main topics were protein biochemistry, Drosophila husbandry, and genetics.
- Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
Abstract " Aims: A causal link between non-ischaemic heart failure (HF) and humoral autoimmunity against G-protein-coupled
- Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Mthl10
GPCRs in Oncology and Immunology Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression SRP gene expression has been also demonstrated to be enhanced by GBP, indicating that both cytokines GBP2 expression. GBP2 is an upstream expressional regulator of a GBP1/GBP2 cytokine network. GBP2-induced enhancement of GBP1 expression was not observed in Mthl10 knockdown cells.
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
< GPCR News < GPCRs in Oncology and Immunology Expression prevalence and dynamics of GPCR somatostatin Evaluation of receptors expression dynamics was performed for tumor-nodes-metastases (TNM) defined subgroups Our results indicate that two-thirds of tested cores exhibit clinically significant expression of at The expression prevalence of both receptors tends to decline with tumor progression.
- PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
QRT-PCR was used to validate the expression of PAXIP1-AS1 in OC cell lines. Low PAXIP1-AS1 expression in OC was associated with age (P = 0.045), histological grade (P = 0.011), Low PAXIP1-AS1 expression predicted a poorer overall survival (OS) (HR: 0.71; 95% CI: 0.55-0.92; P = The expression of PAXIP1-AS1 was associated with immune infiltration. low expression of PAXIP1-AS1 was There were some genomic variations between the PAXIP1-AS1 high and low expression groups.
- Ep 151 with Dr GPCR Board
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over
- Chemokine Physiology in Cancer
Abstract Chemokines are chemotactic cytokines whose canonical functions govern movement of receptor expressing Chemokines are a physiologic system that is finely tuned by ligand and receptor expression, ligand or receptor oligomerization, redundancy, expression of atypical receptors and non-GPCR binding partners In cancer, chemokines play paradoxical roles in both the directed emigration of metastatic, receptor-expressing
- GPCR Retreat Schedule 2023
Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects Read More Friday, November 3rd / 3:00 PM Coffee Break 4 Read More Friday, November 3rd / 3:30 PM G Proteins
- A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages
Abstract "Adenosine 2a receptor (A2aR), a typical GPCR with a high affinity for adenosine, is widely expressed Here, we identify that A2aR is specifically expressed on tumor cells from lung adenocarcinoma (LUAD) Constructing models of TAMs and LUAD mice, we find that A2aR highly expressed on LUAD cells promotes
- Transcriptomic analysis of human cytomegalovirus to survey the indirect effects on renal transplant recipients
The resulted raw data were analyzed by conventional RNA-Seq software to determine the Differentially Expressed Eventually, the relative expressions of some significant genes were validated in the twenty external The expression levels of six genes involved in enriched pathways including F3, PTX3, ADRA2B, GNG11, GP9
- GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis
This study demonstrates that GPR37, a GPCR receptor, is highly expressed in CRC. Further tests showed that GPR37 protects cancer cells from ferroptosis by upregulating SCD1 expression
- Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling
We report that efferocyte-derived EVs express prosaposin, which binds to macrophage GPR37 to increase expression of the efferocytosis receptor Tim4 via an ERK-AP1-dependent signaling axis, leading to increased
- CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes
Since only migratory DCs express this chemokine receptor, it is unclear how monocytes reach the LN. Migratory monocytes expressed Ccr5, a high-affinity receptor for Ccl5.
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
Here, we show that HRH1 is widely expressed in various cancer cell lines and cancer tissues and that coexpression of CXCR4 and HRH1 is associated with poor prognosis in breast cancer. activation of CXCR4 and HRH1 synergistically increases calcium flux in MDA-MB-231 cells that endogenously express Enhanced calcium signaling and cell migration are also observed in NCI-H23 and HeLa cells, which coexpress
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
Next, A GPI-anchored pH reporter, pHluorin2, was stably expressed in U87 glioblastoma cells to probe to demonstrate how glioblastoma cells acidify their microenvironment to activate the commonly over expressed In this context, GPR68 suppresses ATF4, inhibition of GPR68 increases expression of ATF4 which leads
- Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
Results show that the elevated expression of UCA1 enhances cell proliferation, invasive migration, and UCA1 expression inversely correlates with survival outcomes and therapy response in ovarian cancer clinical